Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 4520916, 11 pages
https://doi.org/10.1155/2017/4520916
Research Article

Huang Gan Formula Eliminates the Oxidative Stress Effects of Advanced Oxidation Protein Products on the Divergent Regulation of the Expression of AGEs Receptors via the JAK2/STAT3 Pathway

1Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
2Department of Pharmacy, Shenzhen Hospital, Southern Medical University, Shenzhen 518000, China

Correspondence should be addressed to Xixiao Yang; moc.liamtoh@oaixixy

Received 6 December 2016; Accepted 27 February 2017; Published 30 March 2017

Academic Editor: Yoshiji Ohta

Copyright © 2017 Quanwen Deng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Saldanha, V. O. Leal, F. Rizzetto et al., “Effects of resveratrol supplementation in Nrf2 and NF-κB expressions in nondialyzed chronic kidney disease patients: a randomized, double-blind, placebo-controlled, crossover clinical trial,” Journal of Renal Nutrition, vol. 26, no. 6, pp. 401–406, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. A.-S. Bargnoux, M. Morena, S. Badiou, A.-M. Dupuy, B. Canaud, and J.-P. Cristol, “Carbonyl stress and oxidatively modified proteins in chronic renal failure,” Annales de Biologie Clinique, vol. 67, no. 2, pp. 153–158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-Y. Guh, J.-S. Huang, H.-C. Chen, W.-C. Hung, Y.-H. Lai, and L.-Y. Chuang, “Advanced glycation end product—induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1,” American Journal of Kidney Diseases, vol. 38, no. 5, pp. 1096–1104, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Cao, F. F. Hou, and J. Nie, “AOPPs and the progression of kidney disease,” Kidney International Supplements, vol. 4, no. 1, pp. 102–106, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Witko-Sarsat, V. Gausson, A.-T. Nguyen et al., “AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients,” Kidney International, vol. 64, no. 1, pp. 82–91, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. X. F. Wei, Q. G. Zhou, F. F. Hou, B. Y. Liu, and M. Liang, “Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase,” American Journal of Physiology—Renal Physiology, vol. 296, no. 2, pp. F427–F437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Witko-Sarsat, M. Friedlander, T. N. Khoa et al., “Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure,” Journal of Immunology, vol. 161, no. 5, pp. 2524–2532, 1998. View at Google Scholar · View at Scopus
  8. K. Šebeková, K. Klenovicsová, J. Ferenczová, J. Hedvig, L. Podracká, and A. Heidland, “Advanced oxidation protein products and advanced glycation end products in children and adolescents with chronic renal insufficiency,” Journal of Renal Nutrition, vol. 22, no. 1, pp. 143–148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Cai, J. C. He, L. Zhu, C. Lu, and H. Vlassara, “Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 37, pp. 13801–13806, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Torreggiani, H. Liu, J. Wu et al., “Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia,” The American Journal of Pathology, vol. 175, no. 4, pp. 1722–1732, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Tang and A. Chen, “Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling,” Laboratory Investigation, vol. 94, no. 5, pp. 503–516, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-S. Huang, J.-Y. Guh, W.-C. Hung et al., “Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells,” Biochemical Journal, vol. 342, no. 1, pp. 231–238, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. C.-Y. Huang, K.-Y. Lai, L.-F. Hung, W.-L. Wu, F.-C. Liu, and L.-J. Ho, “Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes,” Rheumatology, vol. 50, no. 8, pp. 1379–1389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Mo, X. Xiao, S. Song et al., “Protective effect of Huang Gan formula in 5/6 nephrectomized rats by depressing the Wnt/β-catenin signaling pathway,” Drug Design, Development and Therapy, vol. 9, pp. 2867–2881, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Li, Z. Han, W. Bei, X. Rong, J. Guo, and X. Hu, “Oleanolic acid attenuates insulin resistance via NF-κB to regulate the IRS1-GLUT4 pathway in HepG2 cells,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 643102, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Poteser and I. Wakabayashi, “Serum albumin induces iNOS expression and NO production in RAW 267.4 macrophages,” British Journal of Pharmacology, vol. 143, no. 1, pp. 143–151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Xia, C. Wang, Y. Jin et al., “Luteolin protects HUVECs from TNF-α-induced oxidative stress and inflammation via its effects on the Nox4/ROS-NF-κB and MAPK pathways,” Journal of Atherosclerosis and Thrombosis, vol. 21, no. 8, pp. 768–783, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Cai, M. Torreggiani, L. Zhu et al., “AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-δ: implications for vascular disease,” American Journal of Physiology—Cell Physiology, vol. 298, no. 3, pp. C624–C634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. S. Tucker, V. J. Dalbo, T. Han, and M. I. Kingsley, “Clinical and research markers of oxidative stress in chronic kidney disease,” Biomarkers, vol. 18, no. 2, pp. 103–115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Xie, S. Sun, A. Xu et al., “Advanced oxidation protein products induce intestine epithelial cell death through a redox-dependent, c-jun N-terminal kinase and poly (ADP-ribose) polymerase-1-mediated pathway,” Cell Death & Disease, vol. 5, no. 1, Article ID e1006, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Miyata, Y. Wada, Z. Cai et al., “Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure,” Kidney International, vol. 51, no. 4, pp. 1170–1181, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Descamps-Latscha, V. Witko-Sarsat, T. Nguyen-Khoa et al., “Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers,” Kidney International, vol. 66, no. 4, pp. 1606–1612, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Y. Kim, H. K. Park, J. S. Yoon et al., “Advanced glycation end product (AGE)-induced proliferation of HEL cells via receptor for AGE-related signal pathways,” International Journal of Oncology, vol. 33, no. 3, pp. 493–501, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. V. M. Monnier, D. R. Sell, R. H. Nagaraj et al., “Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia,” Diabetes, vol. 41, supplement 2, pp. 36–41, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. A. M. Schmidt, S. D. Yan, S. F. Yan, and D. M. Stern, “The biology of the receptor for advanced glycation end products and its ligands,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1498, no. 2-3, pp. 99–111, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Ramasamy, S. F. Yan, and A. M. Schmidt, “The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes,” Vascular Pharmacology, vol. 57, no. 5-6, pp. 160–167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Lu, J. C. He, W. Cai, H. I. Liu, L. Zhu, and H. Vlassara, “Advanced glycation product (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 32, pp. 11767–11772, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Brett, A. M. Schmidt, S. D. Yan et al., “Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues,” The American Journal of Pathology, vol. 143, no. 6, pp. 1699–1712, 1993. View at Google Scholar · View at Scopus
  29. Y. M. Li, T. Mitsuhashi, D. Wojciechowicz et al., “Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 20, pp. 11047–11052, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. S.-I. Yamagishi, K. Nakamura, T. Matsui, S. Ueda, K. Fukami, and S. Okuda, “Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications,” Expert Opinion on Investigational Drugs, vol. 17, no. 7, pp. 983–996, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Lin, Y. Tang, Q. Kang, and A. Chen, “Curcumin eliminates the inhibitory effect of advanced glycation end-products (AGEs) on gene expression of AGE receptor-1 in hepatic stellate cells in vitro,” Laboratory Investigation, vol. 92, no. 6, pp. 827–841, 2012. View at Publisher · View at Google Scholar · View at Scopus